ESMO® 2026 Highlights: Presenter Vignettes – Josep Llovet

Dr. Josep Llovet

Josep Llovet

MD, PhD

University of Barcelona

1678RO

Phase 3 LEAP-012 Study of Lenvatinib + Pembrolizumab vs Dual Placebo With Transarterial Chemoembolization (TACE) for Unresectable Non-metastatic Hepatocellular Carcinoma: Long-term OS Results